The insurer is actively seeking ways to mitigate the financial impact of its star ratings drop, Elevance CEO Gail Boudreaux said during the insurer’s third-quarter earnings call.| Healthcare Dive
The payer is taking issue with how regulators calculated quality scores for 2024, after seeing a stars decline that could cause its bonus revenue to fall by $500 million.| Healthcare Dive
About 42% of Medicare Advantage plans that offer prescription drug coverage in 2024 earned four or more stars, compared with just over half this year.| Healthcare Dive
Volatility in MA stars for the 2023 plan year is raising questions around the earnings outlooks issued by payers.| Healthcare Dive
